Scaled Medication Management Program Delivers 6.9x ROIÂ
A large regional Medicare Advantage health plan partnered with Clarest Health to deploy a comprehensive Medication Therapy Management (MTM) and adherence program across two Medicare Part D contracts. Over a 12-year partnership, with the most recent program year spanning 2025 into Q1 2026, the plan achieved measurable gains in CMR completion, medication adherence, member experience, and quality Star ratings, while generating meaningful reductions in total cost of care consistent with published clinical evidence.
The program is estimated to decrease the monthly cost per engaged member by $55 and generate $3.8M in combined program value, a return of approximately 6.9x on the plan’s investment in 2025. Download our most recent case study to learn more and see key impact areas.